Today's Date: March 28, 2024
Saviynt Debuts One-Stop Resource Exchange for Thousands of Enterprise Identity Professionals   •   THE ST. JAMES AND TPH ACADEMY PARTNER TO LAUNCH PREMIER ACADEMIC AND SPORTS PERFORMANCE ACADEMY SERVING THE GREATER WASHINGTON R   •   Guaranteed Rate Welcomes New Atlanta Branch Manager, Carlos Mata   •   Jack Link’s® Unveils a Sweet Collaboration with Dr Pepper® That Brings Two Classic Tastes Together   •   Lutheran Senior Services and Diakon Enter Into Senior Living Agreement   •   Leading In-Home Care Franchise Looks to Expand in La Crosse   •   Stamp showcasing maamoul commemorates Islamic festivals of Eid al-Fitr and Eid al-Adha   •   In 23rd Annual Sexual Assault Awareness Month Campaign, NSVRC Calls for Building Connected Communities to Prevent Sexual Violenc   •   Boston Children’s Hospital and NRG Energy celebrate $1 million milestone, thanks to the Choose to Give program   •   Yamaha Motor Signs Technical Partnership with Lola Cars for Development and Supply of Powertrains for Formula E   •   Intown Stars Sports Training and Events Center Wins Georgia Business Journal's 'Best of Georgia' and Atlanta Magazine's 'Best of   •   From Tee to Triumph: Teen Entrepreneur and Golf Sensation Hosts First Annual Autism Awareness Golf Tournament   •   Green Boom Expands Product Line to The Home Depot   •   Children's Hospital of Philadelphia's Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Earns Two Press Ganey Awards   •   The Religious Sub-forum of BFA 2024 to Feature the First Roundtable Thought Event   •   /R E M I N D E R -- Travelling for Easter? The Canada Border Services Agency gives tips for a smooth trip/   •   Modern Health & Naomi Osaka’s Hana Kuma Launch Mental Health Focused Video Podcast Series “Can’t Wait To H   •   Black & Veatch Distributed Infrastructure Business Awarded Highest OSHA Star Recognition   •   ComPsych Corporation Announces 2023 Health at Work Award Winners   •   Tractor Supply Opens Applications for Second Annual Open Buying Days Event
Bookmark and Share

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NE

LOS ANGELES , February 03 /Businesswire/ - The Law Offices of Frank R. Cruz reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) securities between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On November 4, 2021, NeoGenomics disclosed that it was “conducting an internal investigation with the assistance of outside counsel that focuses on the compliance of certain consulting and service agreements with federal healthcare laws and regulations” and had recently “notified the Office of the Inspector General of the U.S. Department of Health and Human Services of our investigation.” The Company also revealed that it had “accrued a reserve of $10.5 million for potential damage and liabilities associated with the federal healthcare program revenue received spanning multiple years.”

On this news, NeoGenomics’ stock price fell $8.18, or 17.6%, to close at $38.35 per share on November 4, 2021, thereby injuring investors.

Then, on March 28, 2022, after the market closed, NeoGenomics announced that its Chief Executive Officer, Mark Mallon, had resigned, less than a year after accepting the position. The Company also stated that revenue for first quarter 2022 would be “below the low end of its prior guidance of $118 - $120 million” and withdrew its fiscal 2022 guidance.

On this news, NeoGenomics’ stock price fell $5.30, or 29.8%, to close at $12.49 per share on March 29, 2022, thereby injuring investors further.

Then, on April 27, 2022, NeoGenomics announced disappointing financial results for Q1 2022, including an EBITDA loss of $19 million, that consolidated gross profit had decreased by 8% compared to the previous year, and that operating expenses had increased by 59% compared to the previous year.

On this news, NeoGenomics’ stock price fell $0.41, or 3.8%, to close at $10.44 per share on April 27, 2022, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) NeoGenomics was anything but a “one-stop-shop” for cancer testing because it did not offer the most technologically advanced NGS tests, which led to a significant decrease in revenue as current and prospective customers went elsewhere for their testing needs; (2) the Company’s costs were not fixed because NeoGenomics needed to hire additional employees to process more complex customized testing demanded by customers utilizing the Company’s outdated portfolio of tests, leading to operational challenges, decreased lab efficiency, and increased testing turnaround times; (3) NeoGenomics violated federal healthcare laws and regulations related to fraud, waste, and abuse; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased or otherwise acquired NeoGenomics securities during the Class Period, you may move the Court no later than February 6, 2023 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


STORY TAGS: Class Action Lawsuit, Professional Services, Legal, Lawsuit, California, United States, North America,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News